Opinion
Video
Examining The Pathophysiology Of Bronchiectasis
Panelists discusses how the "vicious vortex model" explains bronchiectasis pathophysiology, where airway dilatation leads to mucus stagnation, chronic infections, and neutrophilic inflammation, worsening the condition.
Clinical Brief: Understanding Bronchiectasis Pathophysiology
Main Discussion Topics
- Symptoms of bronchiectasis include cough, sputum production, and shortness of breath, similar to other respiratory diseases but with distinguishing features
- Bronchiectasis involves irreversible, dilated airways visible on imaging, unlike asthma (which is more reversible) and COPD (which presents with emphysema)
- Diagnostic differentiation between bronchiectasis, asthma, and COPD is important despite symptom overlap
Key Points for Physicians
- Patients with bronchiectasis typically present with more copious mucus production and recurrent infections
- On imaging, bronchiectasis appears as irreversibly dilated airways
- COPD typically presents with emphysema (destroyed alveolar areas) on imaging
- Asthma has day-to-day or diurnal variability and is generally more reversible
Notable Insights
Bronchiectasis is structurally distinct from both asthma and COPD despite sharing similar respiratory symptoms, making accurate diagnosis crucial for appropriate management.
Clinical Significance
Understanding the pathophysiological differences between bronchiectasis, asthma, and COPD is essential for accurate diagnosis and targeted management strategies.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
